Growth Metrics

Emergent BioSolutions (EBS) Goodwill & Intangibles (2016 - 2026)

Emergent BioSolutions has reported Goodwill & Intangibles over the past 17 years, most recently at $470.4 million for Q1 2026.

  • For Q1 2026, Goodwill & Intangibles fell 3.05% year-over-year to $470.4 million; the TTM value through Mar 2026 reached $470.4 million, down 3.05%, while the annual FY2025 figure was $436.5 million, 12.96% down from the prior year.
  • Goodwill & Intangibles for Q1 2026 was $470.4 million at Emergent BioSolutions, up from $436.5 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $949.8 million in Q3 2022 and troughed at $436.5 million in Q4 2025.
  • A 5-year average of $630.5 million and a median of $550.4 million in 2024 define the central range for Goodwill & Intangibles.
  • Biggest five-year swings in Goodwill & Intangibles: increased 14.17% in 2022 and later plummeted 40.17% in 2023.
  • Year by year, Goodwill & Intangibles stood at $947.0 million in 2022, then plummeted by 40.17% to $566.6 million in 2023, then dropped by 11.49% to $501.5 million in 2024, then decreased by 12.96% to $436.5 million in 2025, then grew by 7.77% to $470.4 million in 2026.
  • Business Quant data shows Goodwill & Intangibles for EBS at $470.4 million in Q1 2026, $436.5 million in Q4 2025, and $452.7 million in Q3 2025.